Filing Details

Accession Number:
0001127602-15-027731
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-09-28 17:40:07
Reporting Period:
2015-09-24
Filing Date:
2015-09-28
Accepted Time:
2015-09-28 17:40:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884731 Ariad Pharmaceuticals Inc ARIA Biological Products, (No Disgnostic Substances) (2836) 223106987
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1494892 Frank Haluska C/O Ariad Pharmaceuticals, Inc.
26 Landsdowne Street
Cambridge MA 02139
Svp, Clinical R&D, Cmo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-24 10,000 $0.00 127,724 No 4 M Direct
Common Stock Disposition 2015-09-28 5,500 $6.46 122,224 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance stock unit Disposition 2015-09-24 10,000 $0.00 10,000 $0.00
Common Stock Performance stock unit Acquisiton 2015-09-24 20,000 $0.00 20,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
10,000 No 4 M Direct
20,000 No 4 A Direct
Footnotes
  1. Shares were acquired upon vesting of performance stock units awarded on March 19, 2013.
  2. Represents shares sold to satisfy withholding tax requirements, pursuant to a Rule 10b5-1 trading plan.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.22 to $6.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Security and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the range set forth in this footnote.
  4. Each performance stock unit represents a right to receive one share of ARIAD common stock.
  5. The performance stock units vest as to 50% of the award on 9/24/15 and 50% of the award on 9/24/2016.